ORLANDO, FL USA (UroToday.com) - There is a known association between hypertension (HTN) and nephrolithiasis. Abnormalities in renal calcium metabolism in hypertensive patients can lead to increased urinary calcium excretion. The research group sought to evaluate differences in 24-hour urine parameters between patients with and without HTN in a large cohort of stone formers.

auaThis retrospective study consisted of patients with a 24-hour urinalysis (Litholink®) available, and a history of HTN in the demographic data. Univariate t test and multivariate analysis were performed comparing the 24-hour urinalysis profiles of patients with HTN to that of normotensive patients.

A total of 1 115 patients were included, 442 (40%) had HTN and 673 (60%) did not. Univariate analysis revealed significantly greater urine sodium and potassium (p < 0.05), and significantly lower urine pH, calcium, supersaturation (SS) of calcium oxalate (CaOx) and SS calcium phosphate (all p < 0.05) in hypertensive patients. Multivariate analysis showed significantly lower calcium (mean difference=-20.13), citrate (-74.04), phosphate (-0.043), and SS CaOx (-0.648) in patients with HTN.

The research group showed significant lowered 24-hour urine calcium and SS CaOx in hypertensive patients on both univariate and multivariate analyses. In addition, they demonstrated significantly lower 24-hour urine citrate on multivariate analysis.

In conclusion, lower levels of stone inhibitors such as citrate may play a greater role in stone formation in patients with hypertension than deranged calcium metabolism. This finding might help the mitigation of nephrolithiasis in hypertensive patients.

Presented by Christopher Hartman, MD at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

New Hyde Park, NY USA

Written by Achim Lusch, MD, University of California (Irvine), and medical writer for UroToday.com


Upcoming urology industry events
April 27-29, 2018 / European Society for Medical Oncology Update for Practising Oncologists
European Society for Medical Oncology Update for Practising Oncologists
May 14, 2018 / InterContinental Mark Hopkins Hotel
SITC Cancer Immune Responsiveness Workshop
May 16-17, 2018 / InterContinental Mark Hopkins Hotel
SITC Immuno-Oncology Biomarkers: State of the Art Workshop
May 17, 2018 / Moscone Convention Center North/South, San Francisco, CA
SAU 2018 Annual Meeting at the AUA
Print publications focusing on urological cancer treatments through original commentary & articles

Everyday Urology™ - Oncology Insights

From the Editor

Prostate Cancer and Prostatic Diseases

From the Editor